GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.92B |
| Enterprise Value | 5.23B |
| P/E Ratio | 84.96 |
| PEG Ratio | -1.27 |
| Price/Sales Ratio | 2.69 |
| Price/Book Ratio | 2.91 |
| Enterprise/Revenue | 2.95 |
| Enterprise/EBITDA | 38.36 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | 0.05 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 1.7B |
| Revenue/Share | 4.04 |
| Gross Profit | 1.19B |
| EBITDA | 152.9M |
| Net Income | 46.25M |
| Diluted EPS | 0.11 |
Balance Sheet
| Total Cash | 348.24M |
| Total Cash/Share | 0.86 |
| Total Debt | 608.1M |
| Total Debt/Equity | 0.4 |
| Current Ratio | 1.7 |
| Book Value Per Share | 3.92 |
Price History
| 52-Week Change | -13.29 |
| 52-Week High | 17.46 |
| 52-Week Low | 9.51 |
| Moving Average 50 Days | 12.22 |
| Moving Average 200 Days | 12.24 |
Statistics
| Average Volume | 16.39M |
| Shares Outstanding | 403.84M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.06 |
| Trailing Annual Dividend Yield | 0.55 |
| Payout Ratio | 0.69 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
